Cillian King is a Managing Director in the EQT Life Sciences team. Cillian worked for LSP from 2021 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences.
Prior to joining LSP, Cillian worked as an Investment Manager at Swanbridge Capital in Rotterdam, the Netherlands. Prior to Swanbridge Capital, Cillian was an independent consultant for early-stage biotech and medtech companies.
Cillian holds a PhD in Molecular Neurosciences and was trained at the Vrije Universiteit (Amsterdam, the Netherlands) and MIT (Cambridge MA, USA).